These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15197938)

  • 21. Myeloperoxidase as a marker of hemodialysis biocompatibility and oxidative stress: the underestimated modifying effects of heparin.
    Borawski J
    Am J Kidney Dis; 2006 Jan; 47(1):37-41. PubMed ID: 16377383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
    Irion R; Gall H; Peter RU
    Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
    [No Abstract]   [Full Text] [Related]  

  • 23. Guidelines on anticoagulants and the use of LR anesthesia.
    Vandermeulen E
    Acta Anaesthesiol Belg; 2001; 52(4):425-9. PubMed ID: 11799577
    [No Abstract]   [Full Text] [Related]  

  • 24. Activated clotting time (ACT)-guided intravenous dalteparin dosing during percutaneous coronary intervention.
    Marmur JD; Poludasu S; Feit A; Battala VR; Cavusoglu E
    J Invasive Cardiol; 2008 Jul; 20(7):323-7. PubMed ID: 18599887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin.
    Spinler SA; Wittkowsky AK; Nutescu EA; Smythe MA
    Ann Pharmacother; 2005; 39(7-8):1275-85. PubMed ID: 15956240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anticoagulation in patients with heart valve replacement in pregnancy].
    Harenberg J
    Z Kardiol; 1998; 87 Suppl 4():63-7. PubMed ID: 9857469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet therapy or low-dose heparin and neuraxial anaesthesia.
    Schneider MC; Caliezi C; Seeberger MD
    Acta Anaesthesiol Scand Suppl; 1997; 111():219-21. PubMed ID: 9421021
    [No Abstract]   [Full Text] [Related]  

  • 28. Another bleeding heart: perioperative heparin management revisited.
    Harle CC; Murkin JM
    Can J Anaesth; 2007 Feb; 54(2):97-102. PubMed ID: 17272247
    [No Abstract]   [Full Text] [Related]  

  • 29. The safety of heparins in end-stage renal disease.
    Sonawane S; Kasbekar N; Berns JS
    Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of LMW heparin: information for prescribers. Update: 10 April 2002].
    Agence Française de Sécurité Sanitaire Des Produits de Santé (AFSSAPS)
    J Mal Vasc; 2002 Oct; 27(4):231-3. PubMed ID: 12457130
    [No Abstract]   [Full Text] [Related]  

  • 31. Complexoproductive and antiheparin properties of low density lipoproteins (LDL). I. Interaction of isolated low density lipoproteins with heparin of different molecular weight.
    Skrzydlewski Z; Rółkowski R; Worowski K; Lukaszuk C
    Rocz Akad Med Bialymst (1989); 1992; 37():24-31. PubMed ID: 1337474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.
    Hirsh J; Warkentin TE; Raschke R; Granger C; Ohman EM; Dalen JE
    Chest; 1998 Nov; 114(5 Suppl):489S-510S. PubMed ID: 9822059
    [No Abstract]   [Full Text] [Related]  

  • 33. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anticoagulation].
    Matsuda O
    Nihon Rinsho; 1991 Dec; 49 Suppl():279-86. PubMed ID: 1808269
    [No Abstract]   [Full Text] [Related]  

  • 35. Letters on management of ischemic stroke.
    Porat G
    Am Fam Physician; 2012 Sep; 86(6):492. PubMed ID: 23062038
    [No Abstract]   [Full Text] [Related]  

  • 36. Regional citrate anticoagulation for hemorrhage experiments in rats.
    Atkins JL; Barrows E; Byzek SA; Lee CH; Keesee J; Edwards A; Oliver JD
    J Surg Res; 2013 Jan; 179(1):e197-202. PubMed ID: 22504133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview: from heparin to low molecular weight heparin: beyond anticoagulation.
    Mousa SA; Fareed J
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1077-80. PubMed ID: 11892916
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiopulmonary bypass strategy with low-dose heparin and nafamostat mesilate in cardiac surgery: a safe option for patients with acute stroke.
    Morimoto N; Henmi S; Yoshida M; Mukohara N
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):726-8. PubMed ID: 22541513
    [No Abstract]   [Full Text] [Related]  

  • 39. Filter anticoagulation is accomplished through the administration of dilute heparin.
    Michaud D; Komant T; Pfefferle P
    Dynamics; 2000; 11(4):10. PubMed ID: 11982053
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment.
    Rabenstein T; Schneider HT; Bulling D; Nicklas M; Katalinic A; Hahn EG; Martus P; Ell C
    Endoscopy; 2000 Jan; 32(1):10-9. PubMed ID: 10691266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.